Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

NCT06401616 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1220

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Left Atrial Appendage Absent
Anticoagulant Adverse Reaction

Interventions

DRUG: OAC will be discontinued for the duration of the trial

Sponsor

Odense University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]